I. Transradial Vascular Access affords the following advantages over transfemoral access:
- Reduced access site complications Earlier mobility of patients Reduced intensity of post-procedure care.
- Reduced length of hospital stay Expedited throughput in the cath lab.
- Enables outpatient PCI.
- Earlier return to productivity for patients.
- Reduced cost of vascular closure devices.
- Increased comfort for patients.
II. Program Goals:
- Increase utilization of transradial vascular access in USA catheter procedures.
- Encourage a "Radial First" policy and to have transradial access increase in utilization to 50% of all diagnostic and interventional endovascular procedures in the United States by 2025.
III. PAMEAS defined scope of need and develop practical solutions to meet program goals utilizing clinical, industry, policy, and patient representatives.
IV. PAMEAS created educational content for all stakeholders that can increase transradial utilization in USA.
V. PAMEAS raised funds to produce educational materials and create programs.
VI. Produced and managed all aspects of a wide variety of programs for educational and training of stakeholders.
VII. PAMEAS produced over 500 Transradial Summit programs for physicians, nurses, technicians, administrators, industry, policy makers, insurance companies, the press, and patients.
VIII. PAMEAS included patient participation throughout all stages of program development and delivery.
IX. Results to Date:
- PAMEAS Trained more physicians and nurses in classroom and lab settings than any other organization.
- PAMEAS received industry participation and support from a large number of companies.
- PAMEAS was instrumental in policy changes to encourage transradial utilization.
- Transradial utilization in the USA grew from 1.5% in 2006 when this program began to over 22% in 2020.